LagatideAlternative Names: BN 52080
Latest Information Update: 30 Aug 2004
At a glance
- Originator Ipsen
- Class Antidiarrhoeals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 15 Oct 2003 Discontinued - Phase-II for Diarrhoea in France (unspecified route)
- 31 May 2003 Beaufour-Ipsen is now called Ipsen
- 15 Oct 1999 No-Development-Reported for Diarrhoea in France (Unknown route)